← Browse by Condition
Medical Condition

chemotherapy effect

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 3, Phase 2

ClinicalMetric tracks all active clinical trials for chemotherapy effect sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — chemotherapy effect Clinical Trials

How many clinical trials are currently recruiting for chemotherapy effect?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for chemotherapy effect, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for chemotherapy effect?
chemotherapy effect research spans Phase 2 (1 trial), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a chemotherapy effect clinical trial?
Eligibility criteria for chemotherapy effect trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
2
Top Sponsors
The University of Hong Kong 1 trial
Peking Union Medical College Hospital 1 trial
City Clinical Oncology Hospital No 1 1 trial
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1 trial
The First Affiliated Hospital with Nanjing Medical University 1 trial

Recruiting Clinical Trials

NCT05427071
Recruiting
Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant Chemotherapy
Enrollment
30 pts
Location
Hong Kong
Sponsor
The University of Hong Kong
View Trial →
NCT05424692
Recruiting
Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer
Enrollment
200 pts
Location
China
Sponsor
Peking Union Medical College H...
View Trial →
NCT06226857 Phase 3
Recruiting
Other Oncogene Mutations for Anti-EGFR Efficacy in Patients With Left-sided RAS-wild Type Metastatic Colorectal Cancer
Enrollment
355 pts
Location
Russia
Sponsor
City Clinical Oncology Hospita...
View Trial →
NCT05524090
Recruiting
PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer
Enrollment
223 pts
Location
Netherlands
Sponsor
Academisch Medisch Centrum - U...
View Trial →
NCT05983783 Phase 3
Recruiting
Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC
Enrollment
200 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →
NCT04989985 Phase 2
Recruiting
S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma
Enrollment
302 pts
Location
China
Sponsor
Sixth Affiliated Hospital, Sun...
View Trial →
NCT06517927
Recruiting
Prevalence of Long-term Dental Effects of Chemotherapy in Childhood Cancer Survivors Diagnosed With Cancer Before the Age of 10
Enrollment
142 pts
Location
Belgium
Sponsor
Cliniques universitaires Saint...
View Trial →

Related Conditions

breast neoplasm (1) colon cancer (1) rectal cancer (1) ptc (1) exon mutation (1) colorectal neoplasms (1) molecular sequence variation (1) pancreatic cancer (1) locally advanced pancreatic adenocarcinoma (1) pancreatic adenocarcinoma non resectable (1) metastatic prostate cancer (1) hormone sensitive prostate cancer (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology